Pathology Testing Services for HFE Genes
- Published
- 17 July 2026
- Estimated value
- £47,000
- Place of performance
- UKL
- Procedure
- Open procedure
- Lots
- 1
- Notice number
- 067988-2026
- Reference
- ocds-h6vhtk-06b954
- Official source
- Official source
CPV codes
- 85111810Blood analysis services
Description
Betsi Cadwaladr University Health Board intends to award a contract to a provider under the Most Suitable Provider Process for the provision of Pathology Testing Services for HFE Genes including extraction
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Randox Laboratories Ltd | — | — |
Official publications
- FTS · 067988-2026 · 17 July 2026
Other tenders from Betsi Cadwaladr University Health Board
- Edoxaban Review Service W91615
- BCU-DAP2-64184 - ECLO Abergele Hospital
- BCU-DAP2-64188 - ECLO Gwynedd Hospital
- Provision of NHS General Dental Services within the North Denbighshire area
- BCU-FCONC-64071 - Echocardiography Service - Insourcing
- Local Enhanced Clinical Effectiveness Service W94023
- Pathology Testing Services for HFE Genes
- BCU Community Pharmacy Urgent Medicine Service
- BCU Community Pharmacy Urgent Medicine Service
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £47,000.
- Who is the buyer of this tender?
- The contracting authority is Betsi Cadwaladr University Health Board (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.